Goodrx Holdings Inc (GDRX) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.47x

Goodrx Holdings Inc (GDRX) has a Cash Flow Reinvestment Rate of 0.47x as of September 2025, reinvesting $36.00 Million (capex $18.00 Million plus investments $-18.00 Million) from operating cash flow of $76.02 Million. See GDRX FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.47x
(Capex + Investments) / Operating CF

Total Reinvested

$36.00 Million
Capex + Investments

Operating Cash Flow

$76.02 Million
USD

Capital Expenditures

$18.00 Million
USD

Goodrx Holdings Inc Cash Flow Reinvestment Rate (2018–2024)

Historical reinvestment intensity for Goodrx Holdings Inc across 7 annual periods. For the full cash flow conversion analysis, see GDRX operating cash flow.

Annual Cash Flow Reinvestment Rate for Goodrx Holdings Inc (2018–2024)

Year-by-year capital reinvestment analysis for Goodrx Holdings Inc. See GDRX free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2024 0.77x $140.69 Million $183.89 Million $70.35 Million ▲ +8.7%
2023 0.70x $97.37 Million $138.29 Million $55.77 Million ▼ -61.1%
2022 1.81x $265.71 Million $146.78 Million $55.21 Million ▲ +51.8%
2021 1.19x $213.19 Million $178.78 Million $34.46 Million ▲ +22.9%
2020 0.97x $127.44 Million $131.34 Million $35.82 Million ▲ +88.8%
2019 0.51x $42.80 Million $83.29 Million $5.75 Million ▲ +236.3%
2018 0.15x $6.92 Million $45.25 Million $3.46 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow